Publication Date:
2005-11-16
Description:
Microscopic assessment of bone marrow response on Day 7 and/or Day 14 of induction therapy remains a powerful predictor of long-term outcome in childhood acute lymphoblastic leukemia (ALL). Between 1996 and 2000, 2175 Rome/NCI standard risk children, i.e., age 〉1 and 25% (M3) on Day 14, adverse cytogenetics (i.e., t(9;22), t(4;11), or severe hypodiploidy (modal chromosome numbers
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink